AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
Free Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank79
3Y CAGR+66.9%
5Y CAGR-38.5%
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

3Y CAGR
+66.9%/yr
Annual compound
5Y CAGR
-38.5%/yr
Recent acceleration
Percentile
P79
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025273.63%
2024-237.77%
2023-114.43%
202258.86%
2021-50.67%
20203111.27%
2019-78.38%
2018-73.18%
20171185.90%
2016-131.14%